SAN DIEGO, March 20, 2017 -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors in shares of NantHealth Inc (NASDAQ:NH) over alleged Securities Laws Violations by NantHealth Inc.
Investors, who purchased shares of NantHealth Inc (NASDAQ:NH), have certain options and should contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.
The plaintiff alleges that the defendants failed to disclose that Soon-Shiong had donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth, that, as such, the Company and Soon-Shiong participated in the violation of federal tax laws—exposing the Company to possible civil and criminal liability, that the Company improperly recorded orders received from the University of Utah as GPS Cancer test orders, that, as a result, the Company reported false and inflated GPS Cancer order figures for the third quarter of 2016, and that, as a result of the foregoing, the Company’s financial statements and Defendants’ statements about NantHealth’s business, operations, and prospects, were materially false and misleading.
Those who purchased NantHealth Inc (NASDAQ:NH) shares should contact the Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 [email protected] 3111 Camino Del Rio North Suite 423 San Diego, CA 92108


Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
BESI Reports Strong Q4-25 Orders Surge Driven by Data Center and Hybrid Bonding Demand
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S.
China’s AI Sector Pushes to Close U.S. Tech Gap Amid Chipmaking Challenges
Anthropic Launches HIPAA-Compliant Healthcare Tools for Claude AI Amid Growing Competition
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 



